This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: AEO AMGN MCO PNC S


American Eagle (AEO - Get Report) upgraded at Sterne Agee to Buy. $27 price target. Estimates also boosted, as new management initiatives should drive growth.

Advanced Micro (AMD) upgraded at Goldman from Sell to Neutral, Goldman Sachs said. Valuation call, as the stock is down 49% over the past year. $3.50 price target.

Amgen (AMGN - Get Report) upgraded at UBS from Neutral to Buy, UBS said. $96 price target. Expect better near-term clinical data.

Ariad Pharmaceuticals (ARIA) upgraded at BofA/Merrill from Neutral to Buy, Bank of America/Merrill Lynch said. $26 price target. Expect continued strong clinical data in the near term.

Biogen Idec (BIIB) downgraded at UBS from Buy to Neutral, UBS said. $156 price target. Valuation call, as the stock is up 56% from the last upgrade.

Bemis (BMS) rated new Neutral at JPMorgan. $37 price target. Lagging fundamentals balance cash generation story.

Brocade Communications Systems (BRCD) upgraded to buy at TheStreet Ratings.

Colony Financial (CLNY) downgraded to hold at TheStreet Ratings.

Celgene (CELG) downgraded at UBS from Buy to Neutral, UBS said. $80 price target. Valuation call, as the stock is up 27% since Revlimid was not approved in the EU.

Cliffs Natural (CLF) downgraded at Goldman from Buy to Neutral, Goldman Sachs said. $39 price target. Estimates also cut, given lower expected iron ore prices and rising costs.

Carpenter Technology (CRS) upgraded at JPMorgan to Overweight from Neutral, JPMorgan said. $70 price target. Sustainable growth in materials.

Dover (DOV) upgraded at JP Morgan from Underweight to Neutral, JP Morgan said. Valuation call.

Amdocs (DOX) downgraded at Jefferies to Hold from Buy, Jefferies said. $35 price target. Full valuation.

Exelon (EXC) downgraded at Citigroup from Neutral to Sell, Citigroup said. $31 price target. Estimates also cut, given higher expected costs.

Fifth Third Bancorp (FITB) downgraded at Oppenheimer to Perform from Outperform, Oppenheimer said. Catalyst achieved.

Fulton Financial (FULT) upgraded at Sterne Agee to Buy from Hold, Sterne Agee said. $11.50 price target. Attractive valuation.

Hubbell (HUB.B) downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. Stock is already factoring in a late-stage economic recovery.

International Paper (IP) downgraded at Deutsche from Buy to Hold, Deutsche Bank said. $39 price target. Stock is already pricing in a potential price hike, which may not yet materialize.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AEO $14.62 2.17%
AMGN $158.99 0.44%
MCO $96.01 0.30%
PNC $87.91 0.15%
S $3.49 1.75%


Chart of I:DJI
DOW 17,891.16 +117.52 0.66%
S&P 500 2,081.43 +16.13 0.78%
NASDAQ 4,817.5940 +42.2360 0.88%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs